These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 9621276)
1. Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease. Ramasubbu K; Gretz N; Bachmann S J Am Soc Nephrol; 1998 Jun; 9(6):937-45. PubMed ID: 9621276 [TBL] [Abstract][Full Text] [Related]
2. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease. Pey R; Bach J; Schieren G; Gretz N; Hafner M In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866 [TBL] [Abstract][Full Text] [Related]
3. Proliferative activity of cyst epithelium in human renal cystic diseases. Nadasdy T; Laszik Z; Lajoie G; Blick KE; Wheeler DE; Silva FG J Am Soc Nephrol; 1995 Jan; 5(7):1462-8. PubMed ID: 7703384 [TBL] [Abstract][Full Text] [Related]
4. Polycystic kidney disease in Han:SPRD Cy rats is associated with elevated expression and mislocalization of SamCystin. Nagao S; Morita M; Kugita M; Yoshihara D; Yamaguchi T; Kurahashi H; Calvet JP; Wallace DP Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1078-86. PubMed ID: 20719982 [TBL] [Abstract][Full Text] [Related]
6. ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease. Hocher B; Kalk P; Slowinski T; Godes M; Mach A; Herzfeld S; Wiesner D; Arck PC; Neumayer HH; Nafz B J Am Soc Nephrol; 2003 Feb; 14(2):367-76. PubMed ID: 12538737 [TBL] [Abstract][Full Text] [Related]
7. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease. Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334 [TBL] [Abstract][Full Text] [Related]
8. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease. Tao Y; Kim J; Faubel S; Wu JC; Falk SA; Schrier RW; Edelstein CL Proc Natl Acad Sci U S A; 2005 May; 102(19):6954-9. PubMed ID: 15863619 [TBL] [Abstract][Full Text] [Related]
9. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat. Gile RD; Cowley BD; Gattone VH; O'Donnell MP; Swan SK; Grantham JJ Am J Kidney Dis; 1995 Sep; 26(3):501-7. PubMed ID: 7645559 [TBL] [Abstract][Full Text] [Related]
10. Altered expression of type II sodium/phosphate cotransporter in polycystic kidney disease. Vogel M; Kränzlin B; Biber J; Murer H; Gretz N; Bachmann S J Am Soc Nephrol; 2000 Oct; 11(10):1926-1932. PubMed ID: 11004225 [TBL] [Abstract][Full Text] [Related]
11. Kidney Injury Molecule-1 Is Specifically Expressed in Cystically-Transformed Proximal Tubules of the PKD/Mhm (cy/+) Rat Model of Polycystic Kidney Disease. Gauer S; Urbschat A; Gretz N; Hoffmann SC; Kränzlin B; Geiger H; Obermüller N Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231899 [TBL] [Abstract][Full Text] [Related]
12. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats. Wang X; Zhang S; Liu Y; Spichtig D; Kapoor S; Koepsell H; Mohebbi N; Segerer S; Serra AL; Rodriguez D; Devuyst O; Mei C; Wüthrich RP Kidney Int; 2013 Nov; 84(5):962-8. PubMed ID: 23715121 [TBL] [Abstract][Full Text] [Related]
13. Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease. Wahl PR; Le Hir M; Vogetseder A; Arcaro A; Starke A; Waeckerle-Men Y; Serra AL; Wuthrich RP Nephrology (Carlton); 2007 Aug; 12(4):357-63. PubMed ID: 17635750 [TBL] [Abstract][Full Text] [Related]
14. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats. Cowley BD; Ricardo SD; Nagao S; Diamond JR Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease. Schäfer K; Gretz N; Bader M; Oberbäumer I; Eckardt KU; Kriz W; Bachmann S Kidney Int; 1994 Jul; 46(1):134-52. PubMed ID: 7933831 [TBL] [Abstract][Full Text] [Related]
16. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease]. Banković-Calić N; Ogbori MR; Nicman E Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002 [TBL] [Abstract][Full Text] [Related]
17. Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway. Xu T; Wang NS; Fu LL; Ye CY; Yu SQ; Mei CL Mol Biol Rep; 2012 Jul; 39(7):7743-53. PubMed ID: 22415852 [TBL] [Abstract][Full Text] [Related]
19. Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease. Berthier CC; Wahl PR; Le Hir M; Marti HP; Wagner U; Rehrauer H; Wüthrich RP; Serra AL Nephrol Dial Transplant; 2008 Mar; 23(3):880-9. PubMed ID: 18042615 [TBL] [Abstract][Full Text] [Related]
20. Alterations of cathepsins B, H and L in proximal tubules from polycystic kidneys of the Han:SPRD rat. Schaefer L; Han X; Gretz N; Schaefer RM Kidney Int; 1996 Aug; 50(2):424-31. PubMed ID: 8840269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]